SINGAPORE,Nov. 21,2024-- Leading pulp,paper and board producer APRIL Group has further strengthened its commitment to improving public health by donating essential medical equipment to a local health
Tuesday,December 31,2024 – Monday,January 13,2025 (National holiday)
TOKYO,Nov. 21,2024-- BELLUSTAR TOKYO,A Pan Pacific Hotel and HOTEL GROOVE SHINJUKU,A PARKROYAL Hotel (Shinjuku-ku,Tokyo;GeneralM
11-21 BELLUSTAR TOKYO, A Pan Pacific HotelHOTEL GROOVE SHINJUKU, A PARKROYAL Hotel
LONDON,Nov. 19,2024-- As world leaders at COP29 inBaku grapple with the challenge of mobilizing USD 1 trillion annually in climate finance,investment migration has emerged as an innovative financing s
BEIJING,Nov. 19,2024-- In a fully equipped laboratory in Beijing,a dragon-head architectural component from the Tang Dynasty (618-907) discovered at theGuzhou ruins in Xiong\'an New Area,North China\'
BOSTON,Nov. 19,2024-- The RepTrak Company™,the global leader in reputation intelligence,announced a majority recapitalization by Periscope Equity,a Chicago-based private equity firm specializing in
"DigiCoach program" is a pilot program by Singapore Health Promotion Board,Health2Sync,and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of di
HONG KONG,Nov. 19,2024--SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"),an integrated security-related engineering services company in Hong Kong,today annou
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).